In a filing, Climb Bio Inc revealed its Director RA CAPITAL MANAGEMENT, L.P. acquired Company’s shares for reported $0.46 million on Dec 11 ’25. In the deal valued at $2.18 per share,213,099 shares were bought. As a result of this transaction, RA CAPITAL MANAGEMENT, L.P. now holds 3,294,856 shares worth roughly $12.55 million.
Then, RA CAPITAL MANAGEMENT, L.P. bought 101,462 shares, generating $290,181 in total proceeds. Upon buying the shares at $2.86, the Director now owns 3,396,318 shares.
Before that, Brennan Aoife sold 20,618 shares. Climb Bio Inc shares valued at $25,154 were divested by the President and CEO at a price of $1.22 per share. As a result of the transaction, Brennan Aoife now holds 48,132 shares, worth roughly $0.18 million.
William Blair initiated its Climb Bio Inc [CLYM] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Robert W. Baird began covering CLYM with “an Outperform” recommendation on August 15, 2025. Oppenheimer started covering the stock on June 06, 2025. It rated CLYM as “an Outperform”.
Price Performance Review of CLYM
On Monday, Climb Bio Inc [NASDAQ:CLYM] saw its stock jump 27.00% to $3.81. Over the last five days, the stock has gained 110.50%. Climb Bio Inc shares have risen nearly 22.90% since the year began. Nevertheless, the stocks have risen 111.67% over the past one year. While a 52-week high of $3.25 was reached on 12/15/25, a 52-week low of $1.05 was recorded on 04/07/25.
Levels Of Support And Resistance For CLYM Stock
The 24-hour chart illustrates a support level at 2.99, which if violated will result in even more drops to 2.16. On the upside, there is a resistance level at 4.73. A further resistance level may holdings at 5.64.
How much short interest is there in Climb Bio Inc?
A steep rise in short interest was recorded in Climb Bio Inc stocks on 2025-11-28, growing by 0.59 million shares to a total of 1.88 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 1.29 million shares. There was a rise of 31.48%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 22, 2025 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $7 price target.
